Want to see NAII full AI Analyst Report?
Natural Alternatives International (NAII) AI Stock Analysis
Top Page
Natural Alternatives International
(NASDAQ:NAII)
NAII scores poorly primarily due to weakened financial performance (losses, margin compression, and 2026 cash burn) and a strongly bearish technical backdrop (price below all key moving averages with negative MACD). Valuation provides limited support because negative earnings make P/E less meaningful and no dividend yield is available.
Natural Alternatives International Key Performance Indicators (KPIs)
Revenue by SegmentShows how much each business segment contributes to overall sales, indicating which areas drive growth and where diversification or expansion opportunities may exist.
Private Label Contract Manufacturing remains NAII’s revenue engine — it swung from a 2023 trough into a steady partial rebound through 2024–Q1 2026 but hasn’t regained the 2020–2022 highs, suggesting demand normalization rather than a step-change expansion; investors should watch if gains are durable (new contracts vs. restocking/seasonality) and whether margins improve. Patent and Trademark Licensing is a small, volatile tail revenue stream with no clear growth trajectory, so near-term upside depends on scaling contract-manufacturing volume and customer diversification.
The FlyNatural Alternatives International (NAII) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.70M
- Dividend Yield
- ―
- Average Volume (3M)
- 42.51K
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- 0.33
- Revenue Growth
- 9.08%
- EPS Growth
- -52.59%
- Country
- US
- Employees
- 301
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Natural Alternatives International Business Overview & Revenue Model
Company Description
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories....
How the Company Makes Money
NAII primarily makes money through two core revenue streams: (1) contract manufacturing and related services for third-party brands, and (2) sales and licensing/royalty-type monetization of proprietary nutraceutical ingredients. In contract manufactu...
Natural Alternatives International Financial Statement Overview
Summary
Financial performance is weak: profitability has deteriorated into sizable losses (2024–2026) with materially compressed gross and net margins. Cash flow quality is also poor, with operating cash flow and free cash flow turning meaningfully negative in 2026. The balance sheet is not overly levered (debt-to-equity improving to ~0.63), but continued losses are eroding equity and remain the key risk.
Income Statement
26NegativeBalance Sheet
52NeutralCash Flow
33Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 141.35M | 142.51M | 129.86M | 113.80M | 154.01M | 170.97M |
| Gross Profit | 7.83M | 9.00M | 9.29M | 6.87M | 18.16M | 30.51M |
| EBITDA | -4.24M | -4.35M | -2.70M | -4.46M | 8.26M | 17.91M |
| Net Income | -20.70M | -20.70M | -13.57M | -7.22M | 2.52M | 10.71M |
Balance Sheet | ||||||
| Total Assets | 126.45M | 126.45M | 151.94M | 162.34M | 134.15M | 146.00M |
| Cash, Cash Equivalents and Short-Term Investments | 7.39M | 7.39M | 12.32M | 11.98M | 13.60M | 21.83M |
| Total Debt | 49.97M | 49.97M | 59.03M | 60.29M | 30.93M | 31.84M |
| Total Liabilities | 76.49M | 76.49M | 83.51M | 79.75M | 45.38M | 57.48M |
| Stockholders Equity | 49.96M | 49.96M | 68.43M | 82.59M | 88.77M | 88.52M |
Cash Flow | ||||||
| Free Cash Flow | -5.67M | -12.62M | 2.32M | -4.51M | -6.50M | -14.62M |
| Operating Cash Flow | -1.55M | -8.92M | 5.93M | -1.50M | 7.02M | 11.87M |
| Investing Cash Flow | -3.70M | -3.70M | -3.61M | -3.02M | -13.47M | -26.46M |
| Financing Cash Flow | 7.77M | 7.77M | -1.97M | 2.89M | -1.78M | 4.29M |
Natural Alternatives International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NAII, the sentiment is Negative. The current price of 1.07 is below the 20-day moving average (MA) of 1.18, below the 50-day MA of 1.63, and below the 200-day MA of 2.45, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 25.44 is Positive, neither overbought nor oversold. The STOCH value of 19.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NAII.
Natural Alternatives International Risk Analysis
Natural Alternatives International disclosed 22 risk factors in its most recent earnings report. Natural Alternatives International reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksNatural Alternatives International Peers Comparison
Overall Rating
FTLF75Outperform
LFVN59Neutral
NATR51Neutral
USNA47Neutral- NAII40Underperform
HAIN37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FTLF | 75Outperform | $73.63M | 11.88 | 13.98% | ― | 60.61% | -22.94% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| LFVN | 59Neutral | $74.03M | 14.70 | 15.25% | 3.23% | -20.10% | -49.17% |
| NATR | 51Neutral | $215.55M | 12.01 | 11.00% | ― | 6.77% | 34.53% |
| USNA | 47Neutral | $264.40M | -11.86 | -4.16% | ― | 1.57% | -166.61% |
| NAII | 40Underperform | $6.71M | -0.31 | -33.23% | ― | 9.08% | -52.59% |
| HAIN | 37Underperform | $10.84M | -0.04 | -106.47% | ― | -13.23% | 43.34% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NAII | Natural Alternatives International | 1.07 | -1.66 | -60.81% | |
| NATR | Nature's Sunshine Products | 12.25 | -1.51 | -10.97% | |
| HAIN | The Hain Celestial | 0.12 | -0.99 | -89.28% | |
| USNA | USANA Health Sciences Inc | 14.31 | -6.94 | -32.66% | |
| LFVN | LifeVantage Corp | 5.88 | -1.24 | -17.39% | |
| FTLF | Fitlife Brands | 7.84 | -11.47 | -59.40% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 13, 2026